Login
Login

We walk to raise survival rates.

Pancreatic cancer is one of the deadliest major cancers.

Keep the Scandi spirit alive this September and walk to raise survival rates.

Join us September 25, 2026

insert_emoticonRegister
Donate

$6,232 raised

$100,000 Goal

$6,232 raised

$100,000 Goal

tag_faces

Entrants

35

On September 25, 2026 we walk for survival.

We need you!

Since 2020, the ScandiCARE Committee has united all our national offices for Terry's Scandi Walk: a 5KM walk to raising awareness and vital funds for pancreatic cancer research and support programs. Over the past six years initiative has generated over $200,000 to support those affected by pancreatic cancer.

Because progress will not wait, and neither will we.

tag_facesRegister

The World's Toughest Cancer

Pancreatic Cancer is underfunded, understudied and overlooked. We're on a mission to change that. 

Learn More

About Terry

Terry Hay was a man with a vision, a man who was loved dearly by all his friends and family and lived life to the fullest. He was a true entrepreneur, running multiple businesses throughout his lifetime, looking to make a difference.

Read More

See Who Is Stepping Up

1

Joseph Maloney

Raised

$212
2

Annick Belanger

Raised

$128
3

Sylvia Tang

Raised

$108
4

Lynden Wei

Raised

$108
5

LeeAnn Boysen

Raised

$56
Next

You don’t know how strong you are until being strong is your only choice. 

Bob Marley
format_quote

Frequently Asked Questions

What is Pancreatic Cancer North America's (PCNA's) mission?
add remove

Our mission is to fundamentally change the way patients, caregivers and the community experience pancreatic cancer and redefine it from a death sentence to a survivable cancer.


add remove

Pancreatic Cancer North America (formerly known as Pancreatic Cancer Canada) received charitable status in 2006 and has been operating for over 20 years.

Is PCNA a registered charity?
add remove

Yes, PCNA is a registered charity. Our Charitable Registration Number is 84870 1967 RR0001

What makes pancreatic cancer so difficult to diagnose and treat?

add remove
Pancreatic cancer is one of the deadliest cancers because it is so often diagnosed too late. Symptoms are usually vague or don’t appear at all in the early stages, and there is currently no reliable, widely used screening test to catch it early.

By the time it is found, the disease has often already spread, limiting treatment options. Advancing earlier detection and more effective treatments is critical - and urgently needed. Support for research today can help change what’s possible for patients tomorrow.

Why is pancreatic cancer research underfunded compared to other cancers?

add remove
Despite being one of the leading causes of cancer-related death, pancreatic cancer continues to receive disproportionately low research funding. Limited awareness and the fact that too few patients survive long enough to advocate for change have contributed to this gap. The result is a difficult cycle: less funding slows progress, and slow progress makes it harder to attract investment. Increasing support is essential to breaking this cycle and accelerating breakthroughs. Every contribution helps bring much-needed attention and resources to this overlooked disease.